衰弱、握力、神经病理血液生物标志物与痴呆发病:17年纵向人群研究
该研究基于9940名50-75岁人群代表性队列,发现基线衰弱指数最高五分位者17年全因痴呆风险(HR 1.75)和血管性痴呆风险(HR 2.44)显著升高。握力较低与8年随访时神经丝轻链和pTau181血液水平升高相关,并与14年随访时蒙特利尔认知评估得分较低相关。
要点
- 衰弱指数最高五分位者17年全因痴呆风险显著升高(HR 1.75)。
- 衰弱指数最高五分位者血管性痴呆风险亦升高(HR 2.44)。
- 握力较低与神经病理血液标志物升高及认知功能较差相关。
核心结论
- 衰弱是中晚年痴呆的风险因素,应评估有认知下降风险个体的衰弱和握力。
研究设计与样本
- 基于人群代表性的纵向队列研究,纳入9940名50-75岁中晚年个体,随访17年。
主要发现
- 在6357名有17年痴呆信息的子样本中,516例诊断为全因痴呆。
- 衰弱指数最高五分位者全因痴呆风险显著升高(HR 1.75;95% CI 1.18-2.60)。
- 衰弱指数最高五分位者血管性痴呆风险显著升高(HR 2.44;95% CI 1.22-4.91)。
- 8年随访时握力较低与神经丝轻链水平升高(β=-.01,p=.007)和pTau181水平升高(β=-.004,p=.017)相关。
- 14年随访时握力较低与蒙特利尔认知评估得分较低相关(β=.02,p=.042)。
临床怎么用
- 对有认知下降风险的个体应评估衰弱和握力。
局限性
- 痴呆分析基于有随访信息的子样本,可能引入选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: While previous research has demonstrated that frailty is associated with increased dementia risk over time, large multi-decade prospective population-based cohort studies remain limited. Furthermore, the association between lower grip strength and blood-based biomarkers of neuropathology and global cognitive function remains under-investigated. METHODS: We investigated the relationship between varying levels of baseline frailty (measured using a deficit accumulation Frailty Index [FI]) and dementia incidence over 17 years, as well as associations of grip strength (hand, pinch, and key, assessed at 8- and 14-year follow-up) with blood-based biomarkers of neuropathology (year 8) and with global cognitive function (year 14) in a population-representative cohort of 9940 mid- to late-life (50-75 years) individuals. RESULTS: In a subsample of 6357 participants with available dementia information at 17-year follow-up (mean age at baseline [SD], 61.7 [6.6] years; female, 54.3%), 516 received an all-cause dementia diagnosis. Over this time, individuals in the highest FI quintile demonstrated a significantly higher risk of all-cause dementia (hazard ratio [HR], 1.75; 95% CI, 1.18-2.60) and a vascular dementia diagnosis (HR, 2.44; 95% CI, 1.22-4.91). Cross-sectionally, lower handgrip strength was associated with elevated blood levels of neurofilament light chain (β = -.01, p = .007) and pTau181 (β=-.004, p = .017) at 8-year follow-up, as well as poorer cognitive function on the Montreal Cognitive Assessment (β = .02, p = .042) at 14-year follow-up. CONCLUSIONS: This study strengthens evidence that frailty is a risk factor for dementia in mid- to late-life. It also suggests that it is of considerable importance to assess frailty and grip strength in individuals "at risk" of cognitive decline.
引用
- Michaelian JC, Trares K, Stevenson-Hoare J, et al. Frailty, grip strength, blood-based biomarkers of neuropathology, and incident dementia: a 17-year longitudinal population study. J Gerontol A Biol Sci Med Sci. 2026. PMID: 41352972. doi:10.1093/gerona/glaf268
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。